Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Your Article Summary
The role of entecavir in preventing hepatitis B recurrence after liver transplantation
Journal of Digestive Diseases, 10/29/09
Xia Q et al. – The study shows that entecavir combined with low dosages of HBIG is effective and safe in preventing hepatitis B recurrence after liver transplantation, but its long–term effect is still under investigation and a large–sample study will be carried out in the future.
Today in Transplantation...keeping you current
Receive free subspecialty "5-minute updates" via email
Outcomes After Liver Transplant in Patients Aged 70 Years or Older Compared With Those Younger Than 60 Years
Mayo Clinic Proceedings, 11/02/09
Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome
Hepatology, 11/04/09
Hepatocellular carcinoma and evidence-based surgery
World Journal of Gastroenterology, 11/18/09
Sponsor
Article Search
Sponsor


See Latest Articles


